Tamara Vasilkovska
Overview
Explore the profile of Tamara Vasilkovska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
41
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Rooij J, van den Berg M, Vasilkovska T, Van Audekerke J, Kosten L, Bertoglio D, et al.
Front Nutr
. 2025 Feb;
12:1440373.
PMID: 39963669
Introduction: Dietary interventions such as caloric restriction (CR) exert positive effects on brain health. Unfortunately, poor compliance hinders the success of this approach. A proposed alternative is resveratrol (Rsv), a...
2.
Vasilkovska T, Verschuuren M, Pustina D, van den Berg M, Van Audekerke J, Pintelon I, et al.
Clin Transl Med
. 2024 Oct;
14(10):e70055.
PMID: 39422700
Background: Huntington's disease (HD) is marked by irreversible loss of neuronal function for which currently no availability for disease-modifying treatment exists. Advances in the understanding of disease progression can aid...
3.
Vasilkovska T, Salajeghe S, Vanreusel V, Van Audekerke J, Verschuuren M, Hirschler L, et al.
J Biomed Sci
. 2024 Apr;
31(1):37.
PMID: 38627751
Background: Huntington's disease (HD) is marked by a CAG-repeat expansion in the huntingtin gene that causes neuronal dysfunction and loss, affecting mainly the striatum and the cortex. Alterations in the...
4.
Adhikari M, Vasilkovska T, Cachope R, Tang H, Liu L, Keliris G, et al.
Sci Rep
. 2023 Jun;
13(1):10194.
PMID: 37353500
Huntington's disease (HD) is a neurodegenerative disorder caused by expanded (≥ 40) glutamine-encoding CAG repeats in the huntingtin gene, which leads to dysfunction and death of predominantly striatal and cortical...
5.
Vasilkovska T, Adhikari M, Van Audekerke J, Salajeghe S, Pustina D, Cachope R, et al.
Neurobiol Dis
. 2023 Mar;
181:106095.
PMID: 36963694
Huntington's disease is an autosomal, dominantly inherited neurodegenerative disease caused by an expansion of the CAG repeats in exon 1 of the huntingtin gene. Neuronal degeneration and dysfunction that precedes...
6.
van den Berg M, Adhikari M, Verschuuren M, Pintelon I, Vasilkovska T, Van Audekerke J, et al.
Alzheimers Res Ther
. 2022 Oct;
14(1):148.
PMID: 36217211
Background: Imbalanced synaptic transmission appears to be an early driver in Alzheimer's disease (AD) leading to brain network alterations. Early detection of altered synaptic transmission and insight into mechanisms causing...
7.
Bertoglio D, Bard J, Hessmann M, Liu L, Gartner A, De Lombaerde S, et al.
Sci Transl Med
. 2022 Feb;
14(630):eabm3682.
PMID: 35108063
Huntington's disease (HD) is a dominantly inherited neurodegenerative disorder caused by a CAG trinucleotide expansion in the huntingtin () gene that encodes the pathologic mutant HTT (mHTT) protein with an...
8.
Su X, Vasilkovska T, Frohlich N, Garaschuk O
Cell Calcium
. 2021 Jan;
94:102334.
PMID: 33460952
S100B is an EF-hand type Ca-binding protein of the S100 family, known to support neurogenesis and to promote the interactions between brain's nervous and immune systems. Here, we characterized the...